Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
Prevalence of long COVID varies geographically in the United States
Feb 16, 2024
In New England and the Pacific, prevalence tended to be lower, whereas higher prevalence was seen in the South, Midwest and West.
COVID-19 tied to significant increase in outpatient healthcare
Feb 13, 2024
The greatest increase in utilization was seen for veterans aged 85 years and older (6.1 visits) versus those aged 20 to 44 years (4.8 visits).
COVID-19 mRNA vaccines safe during pregnancy
Feb 13, 2024
In a large study, there were lower odds of neonatal mortality associated with vaccination.
Online physical, mental rehab aids quality of life with long COVID
Feb 09, 2024
The findings were clinically significant at three and 12 months versus usual care.
Updated COVID-19 vaccine has effectiveness of 54 percent
Feb 06, 2024
Vaccine effectiveness was 49% at 60 to 119 days after vaccination among tests exhibiting spike gene target failure.
Meds rarely offered for COVID-19 patients at high risk for progression
Jan 25, 2024
No reason other than mild symptoms was given for almost half of patients at high risk for progression who were not offered treatment.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
People with severe mental illness experienced increased COVID-19 mortality
Nov 21, 2023
The risk for death was found to be exacerbated by comorbidities.
Pandemic lockdowns had ‘profound’ effect on senior living residents’ families: study
By
Kimberly Bonvissuto
Nov 17, 2023
Constantly changing guidelines, fractured communication and being abruptly cut off from loved ones in nursing and residential care homes had a “profound” effect on the physical and mental health of...